| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 16.56 | 10.1% | 2.8% |
| Total Income | 16.56 | 10.1% | 2.8% |
| Expenditure | 16.84 | 13.4% | 34.3% |
| PBT | -0.24 | 192.3% | 105.3% |
| Net Profit | -0.28 | 203.7% | 106.2% |
| OPM | -1.67% | 2.90pp | 28.07pp |
| NPM | -1.69% | 3.47pp | 28.07pp |
| EPS | -0.02 | 200.0% | 106.1% |
Champions Oncology Reports Q3 2026 Results
04 May 2026 · 4 May, 12:34 am
Summary
Champions Oncology, Inc. issued a press release regarding the Company’s unaudited financial results for its third quarter ended January 31, 2026. The press release is attached as an exhibit to the 8-K filing.
Key Highlights
- 1
Champions Oncology, Inc. issued a press release regarding the Company’s unaudited financial results for its third quarter ended January 31, 2026.
Informational and educational content only. Not investment advice.